Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration

Detalles Bibliográficos
Autores principales: Simó, Rafael, Hernández, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664137/
https://www.ncbi.nlm.nih.gov/pubmed/37843198
http://dx.doi.org/10.4103/1673-5374.353492
_version_ 1785138551313137664
author Simó, Rafael
Hernández, Cristina
author_facet Simó, Rafael
Hernández, Cristina
author_sort Simó, Rafael
collection PubMed
description
format Online
Article
Text
id pubmed-10664137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-106641372023-09-04 Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration Simó, Rafael Hernández, Cristina Neural Regen Res Perspective Wolters Kluwer - Medknow 2023-09-04 /pmc/articles/PMC10664137/ /pubmed/37843198 http://dx.doi.org/10.4103/1673-5374.353492 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Perspective
Simó, Rafael
Hernández, Cristina
Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title_full Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title_fullStr Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title_full_unstemmed Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title_short Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
title_sort topical ocular administration of dpp-iv inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664137/
https://www.ncbi.nlm.nih.gov/pubmed/37843198
http://dx.doi.org/10.4103/1673-5374.353492
work_keys_str_mv AT simorafael topicalocularadministrationofdppivinhibitorsanewapproachfortreatingdiabetesinducedretinalneurodegeneration
AT hernandezcristina topicalocularadministrationofdppivinhibitorsanewapproachfortreatingdiabetesinducedretinalneurodegeneration

Ejemplares similares